Algorithmic approaches to hemostasis testing

Seminars in Thrombosis and Hemostasis

Volumn 40, Issue 2, 2014, Pages 195-204

  Kottke Marchant, Kandice ^a,b  

^a Laboratory Medicine Institute   (United States)

^b CLEVELAND CLINIC LERNER COLLEGE OF MEDICINE   (United States)

Author keywords

algorithm; hemostasis service; test utilization

Indexed keywords

ARTICLE; BLEEDING; DIAGNOSTIC ERROR; DIFFERENTIAL DIAGNOSIS; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; HEMATOCRIT; HEMOSTASIS; HEMOSTASIS TESTING; HOSPITAL COST; HUMAN; LABORATORY TEST; MEDICAID; MEDICAL CARE; MEDICARE; MOLECULAR WEIGHT; PARTIAL THROMBOPLASTIN TIME; PATIENT CARE; PRIORITY JOURNAL; PROTHROMBIN TIME; THROMBIN TIME; THROMBOELASTOGRAPHY; THROMBOSIS; ALGORITHM; BLOOD; BLOOD CLOTTING TEST; DIAGNOSTIC PROCEDURE; HEMORRHAGE; PATHOLOGY; PATIENT REFERRAL; PROCEDURES; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; STANDARDS;

ALGORITHMS; BLOOD COAGULATION TESTS; CLINICAL LABORATORY TECHNIQUES; HEMORRHAGE; HUMANS; PATHOLOGY, CLINICAL; REFERRAL AND CONSULTATION; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; THROMBOSIS;

EID: 84896721631     PISSN: 00946176     EISSN: 10989064     Source Type: Journal    
DOI: 10.1055/s-0033-1364187     Document Type: Article

References (43)

1. Lynn N. DHHS/OS/ASPE. Short term fixes to the sustainable growth rate process. Available at: http://aspe.hhs.gov/health/reports/08/sgr/sgr.html#es (accessed May 30, 2013)
2. Lippi G., Mattiuzzi C. Testing volume is not synonymous of cost, value and efficacy in laboratory diagnostics. Clin Chem Lab Med: 2013; 51 2 243 245
3. Why do I need a pathology test? http://www.rcpa.edu.au/getattachment/ 4501e94c-251e-4f17-91e8-fa695a7d6139/FctSht2-Why-Path-Test.aspx. Accessed January 16, 2014.
4. McGlynn E. A., Asch S. M., Adams J., et al. The quality of health care delivered to adults in the United States. N Engl J Med: 2003; 348 26 2635 2645
5. Plebani M., Lippi G. Closing the brain-to-brain loop in laboratory testing. Clin Chem Lab Med: 2011; 49 7 1131 1133
6. Laposata M., Dighe A. Pre-pre and post-post analytical error: high-incidence patient safety hazards involving the clinical laboratory. Clin Chem Lab Med: 2007; 45 6 712 719
7. Lippi G., Becan-McBride K., Behúlová D., et al. Preanalytical quality improvement: in quality we trust. Clin Chem Lab Med: 2013; 51 1 229 241
8. Alonso-Cerezo M. C., Martín J. S., García Montes M. A., de la Iglesia V. M. Appropriate utilization of clinical laboratory tests. Clin Chem Lab Med: 2009; 47 12 1461 1465
9. Calderon-Margalit R., Mor-Yosef S., Mayer M., Adler B., Shapira S. C. An administrative intervention to improve the utilization of laboratory tests within a university hospital. Int J Qual Health Care: 2005; 17 3 243 248
10. Zia H. M., Singh G. Optimization of utilization of serum protein analysis: role of the electronic medical record in promoting consultation by pathology. Am J Clin Pathol: 2013; 139 6 793 797
11. Levick D. L., Stern G., Meyerhoefer C. D., Levick A., Pucklavage D. Reducing unnecessary testing in a CPOE system through implementation of a targeted CDS intervention BMC Med Inform Decis Mak: 2013; 13 43
12. CLSI. Collection, Transport and Processing of Blood Specimens for Testing Plasma-Based Coagulation Assays and Molecular Hemostasis Assays; Approved Guideline-Fifth Edition. CLSI document H21-A5. Wayne, PA Clinical and Laboratory Standards Institute: 2008
13. Peters G. L., Erwin P. B., Pitlick M. K., Stacy Z. A. Utilization of coagulation assays in clinical therapeutics. Pharmacotherapy: 2013; 33 1214 1222
14. Favaloro E. J., Lippi G., Adcock D. M. Preanalytical and postanalytical variables: the leading causes of diagnostic error in hemostasis? Semin Thromb Hemost: 2008; 34 7 612 634
15. Lippi G., Salvagno G. L., Adcock D. M., Gelati M., Guidi G. C., Favaloro E. J. Right or wrong sample received for coagulation testing? Tentative algorithms for detection of an incorrect type of sample. Int J Lab Hematol: 2010; 32 1, Pt 2 132 138
16. Lakos G. Interference in antiphospholipid antibody assays. Semin Thromb Hemost: 2012; 38 4 353 359
17. Lippi G., Rossi R., Ippolito L., et al. Influence of residual platelet count on routine coagulation, factor VIII, and factor IX testing in postfreeze-thaw samples. Semin Thromb Hemost: 2013; 39 7 834 839
18. Harenberg J., Giese C., Marx S., Krämer R. Determination of dabigatran in human plasma samples. Semin Thromb Hemost: 2012; 38 1 16 22
19. Castellone D. D., Van Cott E. M. Laboratory monitoring of new anticoagulants. Am J Hematol: 2010; 85 3 185 187
20. Mani H., Hesse C., Stratmann G., Lindhoff-Last E. Ex vivo effects of low-dose rivaroxaban on specific coagulation assays and coagulation factor activities in patients under real life conditions. Thromb Haemost: 2013; 109 1 127 136
21. Favaloro E. J., Lippi G. Problems in laboratory testing: hemophilia and beyond. J Thromb Haemost: 2010; 8 5 1119 1120
22. Page D. A. Change designation of clotting factors to Arabic numerals. J Thromb Haemost: 2009; 7 9 1599
23. Marques M. B., Anastasi J., Ashwood E., et al. Academy of Clinical Laboratory Physicians and Scientists. The clinical pathologist as consultant. Am J Clin Pathol: 2011; 135 1 11 12
24. Kottke-Marchant K., ed. An Algorithmic Approach to Hemostasis Testing. Northfield, IL College of American Pathologists: 2008
25. Laposata M. E., Laposata M., Van Cott E. M., Buchner D. S., Kashalo M. S., Dighe A. S. Physician survey of a laboratory medicine interpretive service and evaluation of the influence of interpretations on laboratory test ordering. Arch Pathol Lab Med: 2004; 128 12 1424 1427
26. Hayward C. P., Moffat K. A., Plumhoff E., Van Cott E. M. Approaches to investigating common bleeding disorders: an evaluation of North American coagulation laboratory practices. Am J Hematol: 2012; 87 01 S45 S50
27. Kratz A., Soderberg B. L., Szczepiorkowski Z. M., Dighe A. S., Versalovic J., Laposata M. The generation of narrative interpretations in laboratory medicine: a description of service-specific sign-out rounds. Am J Clin Pathol: 2001; 116 (Suppl): S133 S140
28. Marlar R. A., Potts R. M., Marlar A. A. Effect on routine and special coagulation testing values of citrate anticoagulant adjustment in patients with high hematocrit values. Am J Clin Pathol: 2006; 126 3 400 405
29. Manco-Johnson M. J., Nuss R., Jacobson L. J. Heparin neutralization is essential for accurate measurement of factor VIII activity and inhibitor assays in blood samples drawn from implanted venous access devices. J Lab Clin Med: 2000; 136 1 74 79
30. Keller F. G., DeFazio J., Jencks F., Steiner M., Rogers J., Ritchey A. K. The use of heparinase to neutralize residual heparin in blood samples drawn through pediatric indwelling central venous catheters. J Pediatr: 1998; 132 1 165 167
31. Kershaw G., Orellana D. Mixing tests: diagnostic aides in the investigation of prolonged prothrombin times and activated partial thromboplastin times. Semin Thromb Hemost: 2013; 39 3 283 290
32. Ledford-Kraemer M. R. Laboratory testing for lupus anticoagulants: pre-examination variables, mixing studies and diagnostic criteria. Semin Thromb Hemost: 2008; 34 380 388
33. Ortel T. L. Laboratory diagnosis of the lupus anticoagulant. Curr Rheumatol Rep: 2012; 14 1 64 70
34. Pengo V. ISTH guidelines on lupus anticoagulant testing. Thromb Res: 2012; 130 01 S76 S77
35. Sahud M. A. Factor VIII inhibitors. Laboratory diagnosis of inhibitors. Semin Thromb Hemost: 2000; 26 2 195 203
36. Nichols W. L., Rick M. E., Ortel T. L., et al. Clinical and laboratory diagnosis of von Willebrand disease: a synopsis of the 2008 NHLBI/NIH guidelines. Am J Hematol: 2009; 84 6 366 370
37. Favaloro E. J. Laboratory testing in disseminated intravascular coagulation. Semin Thromb Hemost: 2010; 36 4 458 467
38. Margetic S. Diagnostic algorithm for thrombophilia screening. Clin Chem Lab Med: 2010; 48 01 S27 S39
39. Chong L. Y., Fenu E., Stansby G., Hodgkinson S.; Guideline Development Group. Management of venous thromboembolic diseases and the role of thrombophilia testing: summary of NICE guidance. BMJ: 2012; 344 e3979
40. Laposata M. Patient-specific narrative interpretations of complex clinical laboratory evaluations: who is competent to provide them? Clin Chem: 2004; 50 3 471 472
41. Lim E. M., Sikaris K. A., Gill J., et al. Quality assessment of interpretative commenting in clinical chemistry. Clin Chem: 2004; 50 3 632 637
42. Hayward C. P., Moffat K. A., Plumhoff E., et al. External quality assessment of platelet disorder investigations: results of international surveys on diagnostic tests for dense granule deficiency and platelet aggregometry interpretation. Semin Thromb Hemost: 2012; 38 6 622 631
43. Hayward C. P., Moffat K. A., Raby A., et al. Development of North American consensus guidelines for medical laboratories that perform and interpret platelet function testing using light transmission aggregometry. Am J Clin Pathol: 2010; 134 6 955 963